Jason R. Buck

Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity.

Sarah A. Scott, Sydney L. Stoops, C. Lindsley, 2009, Bioorganic & medicinal chemistry letters.